- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.25 | Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor | 1 | GlobeNewswire (USA) | ||
| 29.12.25 | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Glucotrack GAAP EPS of -$4.64 | 1 | Seeking Alpha | ||
| 13.11.25 | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Glucotrack, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11.25 | Glucotrack sagt außerordentliche Hauptversammlung mangels Quorum ab | 2 | Investing.com Deutsch | ||
| 06.11.25 | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.10.25 | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.10.25 | Glucotrack, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 29.09.25 | GlucoTrack files to sell 20.06M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
| 29.09.25 | Glucotrack, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 15.09.25 | GlucoTrack stock tumbles after issuing $3.6M convertible note | 2 | Investing.com | ||
| 11.09.25 | Glucotrack, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 11.09.25 | Glucotrack, Inc.: Glucotrack to Participate in the Q3 Virtual Investor Summit | 3 | GlobeNewswire (USA) | ||
| 05.09.25 | Glucotrack, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 15.08.25 | Glucotrack GAAP EPS of -$9.62 | 1 | Seeking Alpha | ||
| 14.08.25 | Glucotrack to submit long-term CGM implant for FDA IDE this year | 1 | MassDevice | ||
| 14.08.25 | Glucotrack, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 14.08.25 | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | 325 | GlobeNewswire (Europe) | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| 06.08.25 | Cardiac electrophysiologist Hirsh joins Glucotrack's clinical team | 1 | Investing.com |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,000 | +1,33 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| SERNOVA BIOTHERAPEUTICS | 0,080 | -5,88 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,021 | +3,96 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,094 | +5,26 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| CO-DIAGNOSTICS | 6,030 | 0,00 % | XFRA C97: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCO-DIAGNOSTICS DL-... ► Artikel lesen | |
| QUIDELORTHO | 27,400 | -4,20 % | QuidelOrtho Corporation: QuidelOrtho Reports Third Quarter 2025 Financial Results | ? Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ? ... ► Artikel lesen | |
| VERU | 2,370 | +1,72 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 151,70 | -0,56 % | Quest Diagnostics und Corewell Health besiegeln Joint Venture für Labordienstleistungen | ||
| SENSEONICS | 5,550 | -0,89 % | Senseonics Holdings, Inc. - 8-K, Current Report | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 | All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T programAcquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR- Antagonist, Phase 3-ready) and TPST-1495... ► Artikel lesen | |
| RADNET | 67,50 | +1,50 % | RadNet expands to Southwest Florida with acquisition of Radiology Regional | ||
| NUWELLIS, INC | 2,020 | -0,98 % | Nuwellis receives patent for blood filtration safety mechanisms |
GLUCOTRACK INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,040 (-1,03 %) liegt der Kurs bei 3,860 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.